Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
03/1996
03/27/1996EP0702672A1 New active compounds
03/27/1996CN1119099A Method for preparing pharmacologically active CNS composition
03/26/1996US5502203 Certain 6,7-dihydro-3(2-nitrophenyl)-1,2-benzisoxazol-4(5H)-ones as intermediates
03/20/1996EP0505465B1 4-Heterocyclyl-piperidine derivatives, their preparation and their use as inhibitors of calcium overload in brain cells
03/20/1996EP0482108B1 Substituted 2-imidazolines and preparation and use thereof
03/20/1996CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines
03/14/1996WO1996007413A1 Compounds and methods for the treatment of cancer
03/13/1996CN1031262C Ring-substituted 2-animo-1,2,3,4-tetra hydronaphthalenes and 3-aminochromanes
03/12/1996US5498726 Preparation of physostigmine carbamate derivatives from physostigmine
03/12/1996US5498623 4(5) substituted imidazoles and their preparation and use
03/06/1996EP0699682A1 Process for the preparation and/or purification of clavulanic acid
03/06/1996EP0587723B1 Quinuclidine derivatives
03/06/1996EP0571471B1 5-heteroyl indole derivatives
03/06/1996CN1117963A 2-aryl-5-trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl) pyrroles
02/1996
02/29/1996WO1996006098A1 Spiro-azabicyclic compounds useful in therapy
02/29/1996WO1996006095A1 Endothelin antagonists
02/29/1996CA2517691A1 Endothelin antagonists
02/28/1996EP0659184B1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof
02/21/1996EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers
02/21/1996CN1117048A A process for preparing an intermediate compound of the benzothiazole compounds
02/21/1996CN1117046A Method for preparing pharmaceutically active CNS compounds
02/20/1996US5492915 Substituted quinolyl compounds exhibiting selective leukotriene B4 antagonist activity
02/18/1996CA2156120A1 3-substituted-2-oxindoles as inhibitors of viral replication
02/15/1996WO1996004261A1 Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
02/15/1996WO1996004260A1 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
02/15/1996CA2196079A1 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
02/14/1996EP0696285A1 Water soluble derivatives of camptothecin and their use as antitumor agents
02/14/1996CN1116847A N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists
02/14/1996CN1116487A 2-aryl-5-trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl)pyrroles
02/08/1996WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors
02/07/1996CN1116204A Processes for the diastereoselective synthesis of nucleosides
02/06/1996US5489688 Process for preparing trans-piperidine-2,5-dicarboxylates
02/06/1996US5489663 Preparation of polyisocyanates containing isocyanurate groups and use thereof
01/1996
01/31/1996CN1115756A Method for preparing pharmaceutically active CNS compounds
01/30/1996CA1338013C Substituted pyrrole, pyrazole and triazole angiotensin ii antagonists
01/24/1996CN1030765C 2-aryl-5-trifluoromethyl-2-pyrroline compounds and process for manufacture of insecticidal, 2-aryl-1(alkoxymethyl)-4-halo-5-(trifluoromethyl)
01/23/1996US5486512 Learning enhancement
01/23/1996CA1337989C Azolylmethyl-cyclopropyl derivatives
01/18/1996WO1996001256A1 Use of 2-[(dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides
01/18/1996WO1996001117A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
01/17/1996CN1115181A Process for the preparation of 9-amino camptothecin
01/17/1996CN1030717C Removing and recovering plant polyphenols
01/17/1996CN1030702C 芪衍生物 Stilbene derivatives
01/16/1996US5484792 Drugs for treatment of urinary incontinence
01/11/1996DE4423612A1 2-[(Dihydro)pyrazolyl-3'-oxymethylen]-anilide, Verfahren zu ihrer Herstelung und ihre Verwendung 2 - [(dihydro) pyrazolyl-3'-oxymethylene] anilides, process for their Herstelung and their use
01/09/1996CA2013895C Substituted 1-¬3-(heteroarylmethoxy)phenyl|alkanols and related compounds in the treatment of asthma, arthritis and related diseases
01/04/1996DE4428152A1 Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung New amido quinoxalinediones, their preparation and use
01/03/1996CN1030604C Methode for preparing of heterocyclic componds
12/1995
12/28/1995WO1995035289A1 Novel amido quinoxaline diones, their production and use
12/28/1995CA2193732A1 Novel amido quinoxaline diones, their production and use
12/27/1995CN1030570C Process for preparing 1.5-benzothiazepine derivatives
12/20/1995EP0679082A4 C10 taxane derivatives and pharmaceutical compositions.
12/20/1995EP0668762A4 Butenyl-substituted taxanes and composition.
12/20/1995CN1113487A Method for preparing pharmaceutically active CNS compounds
12/20/1995CN1113437A A process for preparing a pharmaceutical composition containing benzothiazole compounds
12/13/1995EP0573473B1 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
12/13/1995CN1113244A Novel process
12/13/1995CN1113228A A process for preparing the intermediate of the derivatives of monocycle beta-lactam antibiotics
12/12/1995US5475105 N-substituted azabicycloheptane derivatives
12/12/1995US5475093 Reacting a nitroso compound with a cyanamide or its salt
12/07/1995CA2166988A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives
12/07/1995CA2166987A1 Novel substituted benzimidazoles
12/06/1995CN1112928A Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
11/1995
11/29/1995CN1112558A Azoxycyanobenzodioxane derivatives
11/29/1995CN1030388C Process of manufacture of 1,5-benzothiazepine derivates
11/28/1995US5470965 Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, process for their preparation and related pharmaceutical compositions
11/28/1995US5470561 Anti-plaque compositions containing a zinc salt and 2',4,4'-trichloro-2-hydroxy diphenyl ether
11/28/1995CA1337654C Fused tricyclic lactams as antihypertensive agents
11/23/1995WO1995031437A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
11/22/1995CN1112119A 13-substituted milbemycin derivatives, their preparation and use
11/16/1995WO1995030670A2 Pyranone compounds useful to treat retroviral infections
11/15/1995EP0682027A1 Pyrrolopyrimidine derivatives with antiproliferative action
11/15/1995CN1111637A Phosphonooxymethyl ethers of taxane derivatives
11/14/1995US5466699 (S)-N,N-dimethyl-2-(5-(2-oxo-1,3-oxazolidin -4-ylmethyl)-1H-indole-3-yl)ethylamine; zolmitriptan
11/04/1995CA2148324A1 Pyrrolopyrimidine derivatives having pharmacological activity
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
11/02/1995WO1995029174A1 Process for the diastereoselective synthesis of nucleoside analogues
11/02/1995WO1995029171A1 Preparation of arthropodicidal oxadiazines
11/02/1995WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/02/1995EP0679645A1 Pharmacologically active CNS pyridmidin compounds
11/02/1995EP0679082A1 C10 taxane derivatives and pharmaceutical compositions
10/1995
10/31/1995US5463070 Hypoglycemic hydroxyurea derivatives
10/31/1995US5462954 Antiinflammatory, antiallergens; treating asthma
10/24/1995US5461167 Heterocyclic compounds
10/24/1995CA1337423C 5(and/or 6)substituted 2-(2-imidazolin-2-yl)nicotinic acids, esters and salts, useful as herbicidal agents and novel intermediates for the preparation of said nicotinic acids, esters and salts
10/19/1995WO1995027712A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug
10/18/1995CN1110479A Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/17/1995US5459137 Muscle relaxants, anticonvulsants, neuroprotective agents
10/17/1995CA2037783C Rebeccamycin analogs by tryptophan analogs feeding
10/17/1995CA1337346C Process for preparing 1,5-benzothiazepine derivatives
10/11/1995CN1109876A Process for the preparation of acid chloride compounds
10/11/1995CN1029971C Process for preparating antiviral tetrahydroimidazo (1,4) benzodiazepines
10/04/1995EP0675133A1 13-Substituted milbemycin derivatives, their preparation and use
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
10/04/1995EP0674626A1 Novel selective aromatase inhibiting compounds
10/04/1995EP0674625A1 Amino-substituted pyrazoles having crf antagonistic activity
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
09/1995
09/27/1995CN1029846C Compounds for treating inflammatory bowel disease
09/20/1995EP0672670A1 Process for the preparation of clavulanic acid
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 105